Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China

• Published in: Genetics Research 2022, Vol.2022, p.1901256-11
• Main Authors: Chang, Rong, Zhou, Wenqin, Ye, Yi, Zhang, Xiaofei, Liu, Yanmin, Wu, Jinchun
• Format: Article
• Language: English
• Subjects: Age; Aged; Aspirin; Blood; Blood platelets; Cardiovascular disease; Cardiovascular diseases; Cerebral Infarction; China; Clopidogrel; Clopidogrel - therapeutic use; Complications; Coronary artery disease; Coronary Disease - drug therapy; Coronary Disease - genetics; Cytochrome P-450 CYP2C19 - genetics; Diabetes mellitus; DNA methylation; Gene polymorphism; Genotype; Genotypes; Geographical distribution; Geographical locations; Heart; Heart diseases; Hemoglobin; Humans; Infarction; Ischemia; Ischemic Stroke; Metabolites; Middle Aged; Minority & ethnic groups; Myocardial infarction; Patients; Polymorphism; Polymorphism, Genetic - genetics; Population studies; Populations; Resistance factors; Risk analysis; Risk factors; Signal transduction; Statistical analysis; Stroke; Thromboplastin; Ticlopidine
• ISSN: 1469-5073; 0016-6723; 1469-5073
• DOI: 10.1155/2022/1901256

Objective. Clopidogrel is widely used for preventing ischemic complications related to cardiovascular diseases. However, many patients experience clopidogrel resistance (CR). The polymorphisms of CYP2C19 have been implicated in CR, but CYP2C19 polymorphism considerably varies with both ethnic group and geographical location. This study aimed to investigate the association between CYP2C19 polymorphisms and clopidogrel resistance (CR) in patients with coronary heart disease and ischemic stroke among Han and Tibetan populations in Qinghai Province, China. Methods. From June 2019 to January 2020, patients who were diagnosed with coronary heart disease or cerebral infarction in internal medicine of Qinghai Provincial People’s Hospital and had taken dual antiplatelet drugs were included in this study. Blood was collected and routine items were completed. Whole exome sequencing was performed for CYP2C19 genetic polymorphisms of CYP2C19∗2 (rs4244285), CYP2C19∗3 (rs4986893), and CYP2C19∗17 (rs12248560). Results. A total of 91 patients with coronary heart disease or cerebral infarction (67 Han people (65.99 ± 12.25 years old) and 24 Tibetan (63.6324 Tib years old)) including 52 cases with CR and 39 cases with non-CR were enrolled in this study. For the Han population, the differences in age, glycosylated hemoglobin, activated partial thromboplastin time (APTT), gender, aspirin resistance, and diabetes were significant between the CR and non-CR groups. For the Tibetan population, the two groups showed no significant difference in all indicators. There was no significant difference between CR and non-CR groups for all genotypes (CYP2C19 ∗2, ∗3, and ∗17) in either Han or Tibetan populations. For the Han populations, age, APTT, and aspirin resistance were significantly correlated with CR. Conclusion. The present study indicated that CYP2C19∗2, CYP2C19∗3, and CYP2C19∗17 alleles were not correlated with CR for both Han and Tibetan populations in Qinghai Province, while age, APTT, and aspirin resistance were independent risk factors of CR in this region.